New Products

JERUSALEM — Teva Pharmaceutical Industries announced the launch of Adasuve (loxapine) inhalation powder in a 10-mg dosage. The drug is the first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar disorder in adults.

CINCINNATI — Procter & Gamble’s Oral-B has announced the launch of an oral care app for children — the Disney Magic Timer App by Oral-B.

Created in collaboration with Disney and powered by DreamPlay, the oral care app is designed to helps kids increase brushing time, which is identified by dentists as an area of concern and improvement for children.

CINCINNATI and AIRPORT CITY, Israel — SodaStream, a manufacturer of home beverage carbonation systems, announced that it has entered into an agreement with Sunny Delight Beverages Co., a producer of juice-based drinks. The companies will co-develop flavors like SunnyD Tangy Original Orange and Orange-Strawberry exclusively for the SodaStream system.

MUMBAI and BALTIMORE — Lupin on Wednesday announced that it received approval from the Food and Drug Administration for rifabutin capsules USP, 150 mg — a generic version of Pharmacia and Upjohn Company's Mycobutin capsules. The company's U.S. subsidiary will begin marketing the product soon.

The drug is used for the prevention of disseminated Mycobacterium avium complex disease in patients with advanced HIV infection. Mycobutin capsules had annual sales of $18.6 million in the United States, according to IMS MAT.

WASHINGTON — To provide pharmacist a detail description of each step in the comprehensive medication review, the American Pharmacists Association has published How to Conduct a Comprehensive Medication Review: A Guidebook for Pharmacists, the association has announced.

The new guide covers such areas as:

NEW YORK — U.K. company Kind2Skin has entered the U.S. market with a new line of deodorants designed just for tweens.

NEW YORK — After a two-year hiatus, U.K.’s King of Shaves is back in action and ready to change the manscape of the industry with its new launch Hyperglide razor now available at Target and Target.com.

NEW YORK — Verizon’s Converged Health Management, a remote patient-monitoring medical platform designed to help clinicians and patients manage patients’ health in between doctor visits, recently received Food and Drug Administration 510(k) clearance to run on the iOS mobile operating system, Verizon announced Tuesday. 

Patients and clinicians now will be able to access Verizon’s solution on their iPhones and can use their iPads to access the Converged Health Management portal.